1Progression in the study of clinical pharmacoeconomics of sunitinib for metastatic renal cell carcinomaEXPERT FORUM769-776
3Expression of caspase-3 and β-catenin in differentiated thyroid cancer and its significanceARTICLES782-786
4Expression of talin and vinculin in esophageal carcinoma and theirs clinical significanceARTICLES787-791
5Research on the clinical outcome of advanced gastric cancer treated with oxaliplatin influenced by ERCC1 gene polymorphism in peripheral bloodARTICLES792-796
6The relationship of neuropilin-2 expression with lymphangiogenesis in colorectal carcinomaARTICLES797-802
7Review and analysis of californium-252 neutron brachytherapy on cervical cancer in ChinaARTICLES803-807
9Clinical observation on gemcitabine based chemotherapy in refractory patients with metastatic breast cancerARTICLES812-815
10Clinical observation of lobaplatin plus vinorelbine in treating 32 advanced breast cancer patientsARTICLES816-817
12Clinical indications of chemotherapy-induced tumor marker surge in advanced cancer patientsARTICLES823-826
13Enteral nutrition support at early period used in patients with liver cancer after liver transplantationARTICLES827-830
14Study of the efficacy of high intensive focused ultrasound in combination with three dimensional conformal radiotherapy on treating advanced pancreatic cancerCLINICAL PRACTICE834-836
15Clinical study of endostar combined with chemotherapy for advanced colorectal cancerANTI-ANGIOGENESIS STUDY837-840
16Clinical observation of endostar plus capecitabine and oxaliplatin in liver metastasis of colorectal carcinomaANTI-ANGIOGENESIS STUDY841-843
17Interpretation of guidelines on parenteral and enteral nutrition: Non-surgical oncologyGUIDELINE INTERPRETATION844-851
